Healthcare Professionals
Affinity Pixie
Oxygenation System
Affinity Pixie Oxygenation System
This addition to the Affinity family is part of Medtronic’s commitment to providing more options for pediatric patients undergoing cardiopulmonary bypass.
Overview
View Animation
The Affinity Pixie® Oxygenation System delivers performance and versatility for neonates, infants and small children requiring cardiopulmonary bypass at flow rates up to 2.0 L/min. Its comprehensive system design offers ease of setup, ease of use and minimized prime volumes.
The system features the Affinity Orbit® Holder System, which provides even greater device positioning flexibility to adapt to your preferred circuit setup.
Two biocompatible surface options are provided for the oxygenator and cardiotomy/venous reservoir:
- Durable, Non-leaching End Point Attached Heparin
- Provides thromboresistance and enhanced blood compatibility
- A hydrophilic biosurface option without heparin
- Reduces platelet activation
- Reduces platelet adhesion
- Preserves platelet function2
For Affinity Pixie Oxygenation System product images, visit our Image Gallery
Oxygenator
Affinity Pixie Oxygenator
Advanced Affinity® Oxygenator Technology in a compact, low-prime design
This pediatric oxygenator features:
- 2.0 L/min maximum flow rate with just 48 mL prime
- Medtronic proprietary graduated fiber bundle density technology, together with radial-radial flow path, design with the objective to:
- Enhance gas transfer
- Reduce pressure drop
- Decrease fiber bundle prime volume
- Create uniform blood flow distribution through the bundle
- Cortiva™ BioActive Surface1 and Balance® Biosurface2
- Device and accessories do not contain DEHP
For more information, including product specifications and ordering information, download our product brochure:
For Affinity Pixie Oxygenation System product images, visit our Image Gallery
References
1
Balance® is a registered trademark of Medtronic, Inc. Technology licensed under agreement from BioInteractions, Limited, United Kingdom
Warnings: A strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures. The benefits of extracorporeal support must be weighed against the risk of systematic anticoagulation and must be assessed by the prescribing physician.
Caution: Swedish law restricts devices coated with Cortiva™ BioActive Surface, Trillium Biosurface and Balance Biosurface to sale by or on the order of a physician. For a complete listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompany each product.
References
1
Balance® is a registered trademark of Medtronic, Inc. Technology licensed under agreement from BioInteractions, Limited, United Kingdom
2
See Chart Below.
Comparison between Balance-coated and uncoated in vitro bench test circuits of percentage of platelets that are activated with adenosine diphosphate (ADP @20 μM) in circulating heparinized human blood over time. Error bars represent standard deviation. († indicates p<0.05)
Warnings: A strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures. The benefits of extracorporeal support must be weighed against the risk of systematic anticoagulation and must be assessed by the prescribing physician.
Caution: Swedish law restricts devices coated with Cortiva™ BioActive Surface, Trillium Biosurface and Balance Biosurface to sale by or on the order of a physician. For a complete listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompany each product.